These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The chemotactic response to PDGF-BB: evidence of a role for Ras. Kundra V; Anand-Apte B; Feig LA; Zetter BR J Cell Biol; 1995 Aug; 130(3):725-31. PubMed ID: 7622571 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
4. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling. Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807 [TBL] [Abstract][Full Text] [Related]
5. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. Rosenfeldt HM; Hobson JP; Maceyka M; Olivera A; Nava VE; Milstien S; Spiegel S FASEB J; 2001 Dec; 15(14):2649-59. PubMed ID: 11726541 [TBL] [Abstract][Full Text] [Related]
6. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways. Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109 [TBL] [Abstract][Full Text] [Related]
7. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387 [TBL] [Abstract][Full Text] [Related]
8. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716. Major TC; Keiser JA J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349 [TBL] [Abstract][Full Text] [Related]
18. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878 [TBL] [Abstract][Full Text] [Related]
19. B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Westermark B; Siegbahn A; Heldin CH; Claesson-Welsh L Proc Natl Acad Sci U S A; 1990 Jan; 87(1):128-32. PubMed ID: 2153283 [TBL] [Abstract][Full Text] [Related]
20. The nonreceptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells. Kanda S; Lerner EC; Tsuda S; Shono T; Kanetake H; Smithgall TE J Biol Chem; 2000 Apr; 275(14):10105-11. PubMed ID: 10744691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]